Alpha Profiles · Company Profile

CRISPR Therapeutics AG

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/crispr-therapeutics-ag

Entity: Public listing published
Primary listing: NASDAQ: CRSP
Verification: Partially verified
Last reviewed: 2026-09-15T20:38:02.503876+00:00

Overview

Alpha's canonical identity and public leadership record for CRISPR Therapeutics AG.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

James R. Kasinger

General Counsel and Secretary

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: CRSP DEF 14A executive officersApr 21, 2026

Naimish Patel, M.D.

Chief Medical Officer

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: CRSP DEF 14A executive officersApr 21, 2026

Raju Prasad, Ph.D.

Chief Financial Officer

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: CRSP DEF 14A executive officersApr 21, 2026

Samarth Kulkarni, Ph.D.

Chief Executive Officer

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: CRSP DEF 14A executive officersApr 21, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 15, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.